Suchergebnisse - "Willis, Allison"

PubPharm (183)

11

Dopamine agonists and risk of lung cancer in patients with restless legs syndrome

enthalten in: Pharmacoepidemiology and drug safety | 2023

von Hernandez-Con, P. | Shults, J. | Willis, A. | +1

12

The Water, the Air, the Marines-Camp Lejeune, Trichloroethylene, and Parkinson Disease

enthalten in: JAMA neurology | 2023

von Dorsey, E. | Greenamyre, J. | Willis, A.

CommentIn: JAMA Neurol. 2023 Jul 1;80(7):673-681. - PMID 37184848

13

Seasonal Variation in Neurologic Hospitalizations in the United States

enthalten in: Annals of neurology | 2023

von Hamedani, A. | Thibault, D. | Willis, A.

14

Racial and Ethnic Disparities in Parkinson Disease : A Call to Action

enthalten in: Neurology. Clinical practice | 2023

von Aamodt, W. | Willis, A. | Dahodwala, N.

15

Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2023

von Abraham, D. | Nguyen, T. | Blank, L. | +6

16

Channeling of New Neuropsychiatric Drugs—Impact on Safety and Effectiveness Studies

enthalten in: Neurotherapeutics | 2023

von Abraham, D. | Nguyen, T. | Blank, L. | +6

17

Channeling of New Neuropsychiatric Drugs—Impact on Safety and Effectiveness Studies

enthalten in: Neurotherapeutics | 2023

von Abraham, D. | Nguyen, T. | Blank, L. | +6

18

Channeling of New Neuropsychiatric Drugs—Impact on Safety and Effectiveness Studies

enthalten in: NeuroRX | 2023

von Abraham, D. | Nguyen, T. | Blank, L. | +6

19

Functional Impairment in Individuals With Prodromal or Unrecognized Parkinson Disease

enthalten in: JAMA neurology | 2023

von Miller-Patterson, C. | Hsu, J. | Willis, A. | +1

CommentIn: JAMA Neurol. 2023 Feb 1;80(2):130-132. - PMID 36534382

20

Core concepts in pharmacoepidemiology : Key biases arising in pharmacoepidemiologic studies

enthalten in: Pharmacoepidemiology and drug safety | 2023

von Acton, E. | Willis, A. | Hennessy, S.